RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000069.xml
PDF herunterladen
Semin Liver Dis 2003; 23(1): 021-038
DOI: 10.1055/s-2003-37586
DOI: 10.1055/s-2003-37586
Immune Responses in Hepatitis B Virus Infection
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
03. März 2003 (online)
ABSTRACT
Hepatitis B virus infection is one of the most frequent causes of chronic liver disease worldwide. Even though a preventive vaccine is available, the search for a cure for chronically infected patients remains a high priority to reduce the morbidity and mortality from liver cirrhosis and hepatocellular carcinoma. This review summarizes the immune response in acute, self-limited and chronic hepatitis B; its differential effects on viral replication and liver injury; and prospects for immunotherapy.
KEYWORDS
Liver - hepatitis B virus - T cell - immune response - cytokine
REFERENCES
- 1 Beasley R P, Lin C-C, Hwang L Y, Chen C-S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet . 1981; 2 1129-1133
- 2 Ishikawa R, Biron C A. IFN induction and associated changes in splenic leukocyte distribution. J Immunol . 1993; 150 3713-3727
- 3 Vilcek J SG. Interferons and other cytokines. In: Fields BNKD, Howley PM, eds. Fundamental Virology, Vol 11
Philadelphia: Lippincott-Raven 1996: 341-365
MissingFormLabel
- 4 Salazar-Mather T P, Lewis C A, Biron C A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest . 2002; 110 321-330
- 5 Webster G J, Reignat S, Maini M K. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology . 2000; 32 1117-1124
- 6 Lanier L L. NK cell receptors. Annu Rev Immunol . 1998; 16 359-393
- 7 Salazar-Mather T P, Ishikawa R, Biron C A. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol . 1996; 157 3054-3064
- 8 Bendelac A, Lantz O, Quimby M E. CD1 recognition by mouse NK1+ T lymphocytes. Science . 1995; 268 863-865
- 9 Kawano T, Cui J, Koezuka Y. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science . 1997; 278 1626-1629
- 10 Kakimi K, Lane T E, Chisari F V, Guidotti L G. Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol . 2001; 167 6701-6705
- 11 Kakimi K, Guidotti L G, Koezuka Y, Chisari F V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med . 2000; 192 921-930
- 12 Carnaud C, Lee D, Donnars O. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol . 1999; 163 4647-4650
- 13 Hayakawa Y, Takeda K, Yagita H. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur J Immunol . 2001; 31 1720-1727
- 14 Eberl G, MacDonald H R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol . 2000; 30 985-992
- 15 Baron J L, Gardiner L, Nishimura S. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity . 2002; 16 583-594
- 16 Pasquetto V, Guidotti L G, Kakimi K, Tsuji M, Chisari F V. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med . 2000; 192 529-536
- 17 Thomson A. The Cytokine Handbook.
San Diego: Academic Press 1998
MissingFormLabel
- 18 Brunetto M, Stemler M, Bonino F. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol . 1990; 10 258-261
- 19 Hasegawa K, Huang J, Wands J. Association of hepatitis B viral precore mutants with fulminant hepatitis in Japan. Virology . 1991; 185 460-463
- 20 Liang T J, Hasegawa K, Riman N, Wands J R, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med . 1991; 324 1705-1709
- 21 Okamoto H, Yotsumoto S, Akahane Y. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol . 1990; 64 1298-1303
- 22 Milich D R, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science . 1986; 234 1398-1401
- 23 Schirmbeck R, Melber K, Kuhröber A, Janowicz Z A, Reimann J. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J Immunol . 1994; 152 1110-1119
- 24 Sigal L J, Crotty S, Andino R, Rock K L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature . 1999; 398 77-80
- 25 Ridge J P, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature . 1998; 393 474-478
- 26 Guidotti L G, Rochford R, Chung J. Viral clearance without destruction of infected cells during acute HBV infection. Science . 1999; 284 825-829
- 27 Pavic I, Polic B, Crnkovic I. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J Gen Virol . 1993; 74 2215-2223
- 28 Franco M A, Tin C, Rott L S. Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon. J Virol . 1997; 71 479-486
- 29 Franco A, Guidotti L G, Hobbs M V, Pasquetto V, Chisari F V. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol . 1997; 159 2001-2008
- 30 Maini M K, Boni C, Ogg G S. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology . 1999; 117 1386-1396
- 31 Rehermann B, Fowler P, Sidney J. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med . 1995; 181 1047-1058
- 32 Bertoletti A, Ferrari C, Fiaccadori F. HLA class-I restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A . 1991; 88 10445-10449
- 33 Ferrari C, Bertoletti A, Penna A. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest . 1991; 88 214-222
- 34 Penna A, Fowler P, Bertoletti A. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens. J Virol . 1992; 66 1193-1198
- 35 Missale G, Redeker A, Person J. HLA-A31 and Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med . 1993; 177 751-762
- 36 Nayersina R, Fowler P, Guilhot S. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol . 1993; 150 4659-4671
- 37 Bertoletti A, Chisari F V, Penna A. Definition of a minimal optimal cytotoxic T cell epitope within the hepatitis B virus nucleocapsid protein. J Virol . 1993; 67 2376-2380
- 38 Sette A, Vitiello A, Rehermann B. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol . 1994; 153 5586-5592
- 39 Chisari F V, Ferrari C. Immunobiology and pathogenesis of viral hepatitis. In: Nathanson N, ed. Viral Pathogenesis
Philadelphia: Lippincott-Raven 1997: 745-778
MissingFormLabel
- 40 Del Guercio F M, Sidney J, Hermanson G. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol . 1995; 154 685-693
- 41 Sidney J, Grey H M, Kubo R T, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today . 1996; 17 261-266
- 42 Sidney J, Del Guercio F M, Southwood S. Several HLA alleles share overlapping peptide specificities. J Immunol . 1995; 154 247-259
- 43 Sidney J, Grey H M, Southwood S. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol . 1996; 45 79-93
- 44 Thursz M R, Thomas H C, Greenwood B M, Hill A V. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet . 1997; 17 11-12
- 45 Ishikawa T, Kono D, Chung J. Polyclonality and multispecificity of the CTL response to a single viral epitope. J Immunol . 1998; 161 5842-5850
- 46 Tuttleman J S, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell . 1986; 47 451-460
- 47 Guidotti L G, Matzke B, Schaller H, Chisari F V. High-level hepatitis B virus replication in transgenic mice. J Virol . 1995; 69 6158-6169
- 48 Ando K, Guidotti L G, Wirth S. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol . 1994; 152 3245-3253
- 49 Pasquetto V, Wieland S, Chisari F V. Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte- induced apoptosis. J Virol . 2000; 74 9792-9796
- 50 McClary H, Koch R, Chisari F V, Guidotti L G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol . 2000; 74 2255-2264
- 51 Guidotti L G, Ishikawa T, Hobbs M V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity . 1996; 4 35-36
- 52 Guidotti L G, Borrow P, Brown A. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med . 1999; 189 1555-1564
- 53 Guidotti L G, McClary H, Loudis J M, Chisari F V. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med . 2000; 191 1247-1252
- 54 Dong B, Silverman R H. Alternative function of a protein kinase homology domain in 2′,5′-oligoadenylate dependent RNase L. Nucleic Acids Res . 1999; 27 439-445
- 55 Silverman R H. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res . 1994; 14 101-104
- 56 Terenzi F, deVeer M J, Ying H. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors. Nucleic Acids Res . 1999; 27 4369-4375
- 57 Haller O, Frese M, Kochs G. Mx proteins: mediators of innate resistance to RNA viruses. Rev Sci Tech . 1998; 17 220-230
- 58 Samuel C E. Reoviruses and the interferon system. Curr Top Microbiol Immunol . 1998; 233 125-145
- 59 Kalvakolanu D V, Borden E C. An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest . 1996; 14 25-53
- 60 Wieland S F, Guidotti L G, Chisari F V. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol . 2000; 74 4165-4173
- 61 Tsui L V, Guidotti L G, Ishikawa T, Chisari F V. Post-transcriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte activated hepatocytes. Proc Natl Acad Sci U S A . 1995; 92 12398-12402
- 62 Heise T, Guidotti L G, Chisari F V. La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol . 1999; 73 5767-5776
- 63 Heise T, Guidotti L G, Cavanaugh V J, Chisari F V. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol . 1999; 73 474-481
- 64 Ando K, Moriyama T, Guidotti L G. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med . 1993; 178 1541-1554
- 65 Kakimi K, Lane T E, Wieland S. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med . 2001; 194 1755-1766
- 66 Park J W, Gruys M E, McCormick K. Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). J Immunol . 2001; 166 3763-3770
- 67 Taub D D, Conlon K, Lloyd A R, Oppenheim J J, Kelvin D J. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science . 1993; 260 355-358
- 68 Cook D N, Beck M A, Coffman T M. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science . 1995; 269 1583-1585
- 69 Shields P L, Morland C M, Salmon M. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol . 1999; 163 6236-6243
- 70 Salazar-Mather T P, Orange J S, Biron C A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med . 1998; 187 1-14
- 71 Kaneko Y, Harada M, Kawano T. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med . 2000; 191 105-114
- 72 Toyonaga T, Hino O, Sugai S. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci U S A . 1994; 91 614-618
- 73 Wang H, Gao X, Fukumoto S. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol . 1999; 181 361-370
- 74 Narumi S, Yoneyama H, Inadera H. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma. Cytokine . 2000; 12 1007-1016
- 75 Bonecchi R, Bianchi G, Bordignon P P. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (TH1s) and TH2s. J Exp Med . 1998; 187 129-134
- 76 Mehal W Z, Juedes A E, Crispe I N. Selective retention of activated CD8+ T cells by the normal liver. J Immunol . 1999; 163 3202-3210
- 77 Diepolder H M, Jung M C, Wierenga E. Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol . 1996; 70 7540-7548
- 78 Penna A, Artini M, Cavalli A. Long lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest . 1996; 98 1185-1194
- 79 Rehermann B, Ferrari C, Pasquinelli C, Chisari F V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med . 1996; 2 1104-1108
- 80 Rehermann B, Lau D, Hoofnagle J, Chisari F V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest . 1996; 97 1655-1665
- 81 Chazouilleres O, Mamish D, Kim M. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet . 1994; 343 142-146
- 82 Blum H E, Stowring L, Figus A. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A . 1983; 80 6682-6685
- 83 Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol . 1984; 65 651-655
- 84 Yoffe B, Burns D K, Bhatt H S, Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology . 1990; 12 187-192
- 85 Beasley R P, Hwang L Y, Stevens C E. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology . 1993; 3 135-141
- 86 Ando K, Guidotti L G, Cerny A, Ishikawa T, Chisari F V. Access to antigen restricts cytotoxic T lymphocyte function in vivo. J Immunol . 1994; 153 482-489
- 87 Bertoletti A, Constanzo A, Chisari F V. Cytotoxic T lymphocyte response to a wild-type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med . 1994; 180 933-943
- 88 Bertoletti A, D'Elios M M, Boni C. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology . 1997; 112 193-199
- 89 Valitutti S, Müller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med . 1996; 183 1917-1921
- 90 Chisari F V. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol . 2000; 156 1117-1132
- 91 Bertoletti A, Sette A, Chisari F V. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature . 1994; 369 407-410
- 92 Klenerman P, Rowland-Jones S, McAdams S. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature . 1994; 369 403-407
- 93 Borrow P, Wei X, Horwitz M S. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med . 1997; 3 212-217
- 94 Chang K M, Rehermann B, McHutchison J G. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest . 1997; 100 2376-2385
- 95 Kaneko T, Moriyama T, Udaka K. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope. Eur J Immunol . 1997; 27 1782-1787
- 96 Goulder P J, Phillips R E, Colbert R A. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med . 1997; 3 212-217
- 97 Niewiesk S, Daenke S, Parker C E. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol . 1995; 69 2649-2653
- 98 Lanzavecchia A. Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med . 1997; 185 1717-1719
- 99 Evavold B D, Allen P M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science . 1991; 252 1308-1310
- 100 Sloan-Lancaster J, Evavold B, Allen P. Induction of T-cell anergy by altered T-cell-receptor ligand. Nature . 1993; 363 156-159
- 101 Milich D R. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today . 1988; 9 380-386
- 102 Milich D R, Jones J E, Hughes J L. Is it a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proc Natl Acad Sci U S A . 1990; 87 6599-6603
- 103 Reifenberg K, Deutschle T, Wild J. The hepatitis B virus e antigen cannot pass the murine placenta efficiently and does not induce CTL immune tolerance in H-2b mice in utero. Virology . 1998; 243 45-53
- 104 Merkle H, Deutschle T, Gastrock-Balitsch I. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Virology . 2000; 273 149-159
- 105 Cote P J, Toshkov I, Bellezza C. Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection. Hepatology . 2000; 32 807-817
- 106 Nakamura I, Nupp J T, Cowlen M. Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs. Hepatology . 2001; 33 439-447
- 107 Barnaba V, Franco A, Alberti A. Recognition of hepatitis B envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol . 1989; 143 2650-2655
- 108 Ferrari C, Penna A, Giuberti T. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol . 1987; 139 2050-2058
- 109 Badardin K A, Desmet V J. Interdigitating and dendritic reticulum cells in chronic active hepatitis. Histopathology . 1984; 8 657-667
- 110 Hoofnagle J H, Shafritz D A, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology . 1987; 7 758-763
- 111 Tsai S L, Chen M Y, Lai M Y. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest . 1992; 89 87-96
- 112 Maini M K, Boni C, Lee C K. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus (HBV) infection. J Exp Med . 2000; 191 1269-1280
- 113 Mita E, Hayashi N, Iio S. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun . 1994; 204 468-474
- 114 Lohman B L, Razvi E S, Welsh R M. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol . 1996; 70 8199-8203
- 115 Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol . 1992; 10 411-452
- 116 Koziel M J, Dudley D, Afdhal N. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest . 1995; 96 2311-2321
- 117 Kinkhabwala M, Sehajpal P, Skolnik E. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J Exp Med . 1990; 171 941-946
- 118 Ganchi P A, Sun S C, Greene W C, Ballard D W. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell . 1992; 3 13391352
- 119 Grilli M, Chiu J J, Lenardo M J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol . 1993; 143 1-62
- 120 Beg A A, Ruben S M, Scheinman R I. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention [published erratum appears in Genes Dev 1992;6:2664-2665]. Genes Dev . 1992; 6 1899-1913
- 121 Su F, Schneider R J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A . 1997; 94 8744-8749
- 122 Huang S N, Chisari F V. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology . 1995; 21 620-626
- 123 Chisari F V, Filippi P, Buras J. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A . 1987; 84 6909-6913
- 124 Chisari F V, Klopchin K, Moriyama T. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell . 1989; 59 1145-1156
- 125 Larkin J, Clayton M, Sun B. Hepatitis B virus transgenic mouse model of chronic liver disease. Nat Med . 1999; 5 907-912
- 126 Nakamoto Y, Guidotti L G, Kuhlen C V, Fowler P, Chisari F V. Immune pathogenesis of hepatocellular carcinoma. J Exp Med . 1998; 188 341-350
- 127 Gallimore A, Glithero A, Godkin A. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med . 1998; 187 1383-1393
- 128 Zajac A J, Blattman J N, Murali-Krishna K. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med . 1998; 188 2205-2213
- 129 Boni C, Bertoletti A, Penna A. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest . 1998; 102 968-975
- 130 Boni C, Penna A, Ogg G S. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology . 2001; 33 963-971
- 131 Marinos G, Naoumov N V, Williams R. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology . 1996; 24 991-995
- 132 Lau G K, Suri D, Liang R. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology . 2002; 122 614-624
- 133 Ilan Y, Nagler A, Adler R. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology . 1993; 104 1818-1821
- 134 Jung M-C, Diepolder H M, Spengler U. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol . 1995; 69 3358-3368
- 135 Ferrari C, Penna A, Bertoletti A. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol . 1990; 145 3442-3449
- 136 Milich D R, McLachlan A, Thornton G B, Hughes J L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature . 1987; 329 547-549
- 137 Kakimi K, Isogawa M, Chung J, Sette A, Chisari F V. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J Virol . 2002; 76 8609-8620
- 138 Gallimore A, Dumrese T, Hengartner H, Zinkernagel R M, Rammensee H G. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med . 1998; 187 1647-1657
- 139 Geginat G, Ruppert T, Hengel H, Holtappels R, Koszinowski U H. IFN-gamma is a prerequisite for optimal antigen processing of viral peptides in vivo. J Immunol . 1997; 158 3303-3310
- 140 Sijts A A M J, Ruppert T, Rehermann B. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med . 2000; 191 503-514
- 141 Vitiello A, Ishioka G, Grey H M. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest . 1995; 95 341-349
- 142 Livingston B D, Crimi C, Grey H. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J Immunol . 1997; 159 1383-1392
- 143 Couillin I, Pol S, Mancini M. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens. J Infect Dis . 1999; 180 15-26
- 144 Ulmer J B, Donnelly J J, Parker S E. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science . 1993; 259 1745-1749
- 145 Wang B, Boyer J, Srikantan V. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol . 1993; 12 799-805
- 146 Wang B, Ugen K E, Srikantan V. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A . 1993; 980 4156-4160
- 147 Xiang Z Q, Spitalnick S, Tran M. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology . 1994; 199 132-140
- 148 Michel M L, Davis H L, Schleef M. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci U S A . 1995; 92 5307-5311
- 149 Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel M L. Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg. J Med Virol . 1993; 39 67-74
- 150 Mancini M, Hadchouel M, Davis H L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci U S A . 1996; 93 12496-12501
- 151 Shimizu Y, Guidotti L G, Fowler P, Chisari F V. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol . 1998; 161 4520-4529
- 152 Wirth S, Guidotti L G, Ando K, Schlicht H J, Chisari F V. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J Immunol . 1995; 154 2504-2515
- 153 Pancholi P, Lee D H, Liu Q. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology . 2001; 33 448-454
- 154 Tamaru M, Nishioji K, Kobayashi Y. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. Cytokine . 2000; 12 299-308
- 155 Murai M, Yoneyama H, Harada A. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest . 1999; 104 49-57
- 156 Lin M T, Hinton D R, Stohlman S A. Mechanisms of viral clearance in perforin-deficient mice. Adv Exp Med Biol . 1998; 440 431-436
- 157 Parra B, Hinton D R, Marten N W. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol . 1999; 162 1641-1647
- 158 Gebhard J R, Perry C M, Harkins S. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol . 1998; 153 417-428
- 159 Horwitz M S, Krahl T, Fine C, Lee J, Sarvetnick N. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol . 1999; 73 1756-1766
- 160 Benihoud K, Saggio I, Opolon P. Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha. J Virol . 1998; 72 9514-9525
- 161 Tay C H, Welsh R M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol . 1997; 71 267-275
- 162 Kagi D, Ledermann B, Burki K. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature . 1994; 369 31-37
- 163 Cavanaugh V J, Guidotti L G, Chisari F V. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol . 1997; 71 3236-3243
- 164 Gilles P N, Fey G, Chisari F V. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol . 1992; 66 3955-3960
- 165 Guidotti L G, Guilhot S, Chisari F V. Interleukin 2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways. J Virol . 1994; 68 1265-1270
- 166 Cavanaugh V J, Guidotti L G, Chisari F V. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol . 1998; 72 2630-2637
- 167 Guidotti L G, Borrow P, Hobbs M V. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci U S A . 1996; 93 4589-4594
- 168 Davis G L, Hoofnagle J H, Waggoner J G. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J Med Virol . 1984; 14 141-147
- 169 Sheen I S, Liaw Y F, Lin D Y, Chu C M. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis . 1994; 170 358-361
- 170 Michalak T I, Pasquinelli C, Guilhot S, Chisari F V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest . 1994; 93 230-239
- 171 Niewiesk S, Daenke S, Parker C. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol . 1994; 68 6778-6781
- 172 Tan L C, Gudgeon N, Annels N E. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol . 1999; 162 1827-1835
- 173 Liu T, Khanna K M, Chen X, Fink D J, Hendricks R L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med . 2000; 191 1459-1466
- 174 Ciurea A, Klenerman P, Hunziker L. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc Natl Acad Sci U S A . 1999; 96 11964-11969